Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Adoptive T-cell therapy for virus-associated diseases.
Journal: Clinical microbiology reviews
Published: August 22, 2025
Prophylactic and Therapeutic EBV Vaccination.
Journal: Current topics in microbiology and immunology
Published: June 06, 2025
FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity.
Journal: Cancer immunology research
Published: February 10, 2025
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.
Journal: Clinical & translational immunology
Published: January 31, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.
Journal: CNS drugs
Published: December 10, 2024
The current attitudes and practices of dentists in Australia towards composite repair: A cross-sectional survey study.
Journal: Australian dental journal
Published: September 16, 2024
Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.
Journal: Clinical & translational immunology
Published: September 08, 2024
EphA3 CAR T cells are effective against glioblastoma in preclinical models.
Journal: Journal for immunotherapy of cancer
Published: July 18, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Journal: Nature communications
Published: May 31, 2024
Cell-associated galectin 9 interacts with cytotoxic T cells confers resistance to tumor killing in nasopharyngeal carcinoma through autophagy activation.
Journal: Cellular & molecular immunology
Published: April 27, 2024
Last Updated: 09/26/2026